Biology

Bio Roundup: Agile Approval, Coronavirus Collabs, Spruce's $88M & More

1 month ago   |   By Xconomy

The price of insulin, a life-saving treatment discovered a century ago, has been a flashpoint amid the broader drug pricing debate. The FDA is trying to tame high insulin prices by encouraging price competition. The FDA has historically regarded insulin as a drug. But insulin isn't a chemical drug, it's made from biological material. Under a rule change published this week, the FDA will classify insulin as a biological product. When the change takes effect on March 23, would-be competitors will be able to seek approval for products that are biologically similar to the branded insulin now...
Read more ...

 


Search by Tags

   Biology      Biologic      Biological      Chemicals      Chemical      Drugs      Drug      Boston blog main      Boulder      Denver blog main      Detroit blog main      Europe blog main      Indiana blog main      National      National blog main      National top stories      New York blog main      Raleigh-Durham blog main      San Diego blog main      San Francisco blog main      Seattle blog main      Texas blog main      Wisconsin blog main      AbbVie      Adaptimmune      Agile Therapeutics      Allergan      AstraZeneca      BARDA      Biotech      Blaise Coleman      Bristol-myers Squibb      Clinical trials      Congenital adrenal hyperplasia      Contraception      Coronavirus      COVID-19      Drug Development      EnClear Therapies      Endo International      FDA      Financing      Five Prime      Frank Reynolds      Gavin Wood      Hector Armando Kellum      Hereditary transthyretin amyloidosis      Imara      Immunomedics      Insulin      IPO      Johnson & Johnson      Life Sciences      Loretta Itri      Macular Degeneration      Major Depressive Disorder      Matthew Ottmer      Merck      Neurodegenerative disease      Novartis      OptiNose      Pancreatic Cancer      Pfizer      PixarBio      Q Bio      ResTORbio      Sandoz      Sanofi      Seattle Genetics      Shattuck Labs      Siegfried Reich      Spruce Biosciences      Startups      Taylor Schreiber      Turning Point Therapeutics      VC      Victor Clavelli      VistaGen Therapeutics      Voyager      Women's health  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Keros Therapeutics Raises $96M in Upsized IPO to Fuel Clinical Tests

Keros Therapeutics Raises $96M in Upsized IPO to Fuel Clinical Tests

The financial markets may remain volatile but Keros Therapeutics managed to raise more money in its public market debut than it had initially planned. Late Tuesday the... Read more ...

Gilead Heightens Inflammatory Disease Focus With Second Genome Microbiome Deal

Gilead Heightens Inflammatory Disease Focus With Second Genome Microbiome Deal

Gilead Sciences has signed an agreement with South San Francisco biotech Second Genome to use its microbiome drug development expertise to advance the compounds it is... Read more ...

Organovo Future Unclear After Shareholders Reject Tarveda Merger

Organovo Future Unclear After Shareholders Reject Tarveda Merger

A planned merger between struggling 3-D “bioprinter” Organovo and Tarveda Therapeutics, a privately held cancer drug developer looking to join the public markets through a... Read more ...

In Battle Against COVID-19 Pandemic, Scientists Turn to PacBio Sequencing

In Battle Against COVID-19 Pandemic, Scientists Turn to PacBio Sequencing

Image by Miroslava Chrienova from Pixabay Our team is proud to announce that PacBio has been working closely with customers to help in the fight against the COVID-19 pandemic... Read more ...

Roche Pays $190M to Start RNA Drug Alliance With Arrakis Therapeutics

Roche Pays $190M to Start RNA Drug Alliance With Arrakis Therapeutics

Some diseases have proven difficult to address using conventional tools of drug discovery that target disease-causing proteins. Roche is placing a $190 million bet on Arrakis... Read more ...

Inovio Begins Experimental COVID-19 Vaccine Tests in Healthy Volunteers

Inovio Begins Experimental COVID-19 Vaccine Tests in Healthy Volunteers

Inovio Pharmaceuticals, one of the biotechs developing a vaccine to prevent COVID-19, has received the FDA's OK to start testing its candidate in healthy volunteers. The... Read more ...

Sage Restructuring Halves Staff, Turns Focus to Failed Depression Drug

Sage Restructuring Halves Staff, Turns Focus to Failed Depression Drug

Sage Therapeutics is cutting workers who sell its only commercialized drug in a corporate reorganization that it says allows it to focus on clinical-stage compounds, including... Read more ...

Creating Consistent Value in Biotech Without Diluting Stakeholders

Creating Consistent Value in Biotech Without Diluting Stakeholders

One of the greatest challenges for pre-commercial biotech companies is consistently generating capital necessary for operating costs and for R&D of new products that provide... Read more ...

Interactive, Online Xcelerating Life Sciences Boston Event Set for May 13

Interactive, Online Xcelerating Life Sciences Boston Event Set for May 13

In the Boston biotech hub, much progress has been made advancing digital health, but significant scientific, technological, financial, and regulatory challenges remain. Join us... Read more ...

Bioinspired reorientation strategies for application in micro/nanorobotic...

Abstract Engineers have recently been inspired by swimming methodologies of microorganisms in creating micro-/nanorobots for biomedical applications. Future medicine may be... Read more ...